Evangelia Razis
First Department of Medical Oncology
"Hygeia" Hospital
Er. Stavrou & Kifissias Av
151 23
Greece
Name/email consistency: high
- Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Razis, E., Bobos, M., Kotoula, V., Eleftheraki, A.G., Kalofonos, H.P., Pavlakis, K., Papakostas, P., Aravantinos, G., Rigakos, G., Efstratiou, I., Petraki, K., Bafaloukos, D., Kostopoulos, I., Pectasides, D., Kalogeras, K.T., Skarlos, D., Fountzilas, G. Breast Cancer Res. Treat. (2011)
- Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment. Razis, E., Selviaridis, P., Labropoulos, S., Norris, J.L., Zhu, M.J., Song, D.D., Kalebic, T., Torrens, M., Kalogera-Fountzila, A., Karkavelas, G., Karanastasi, S., Fletcher, J.A., Fountzilas, G. Clin. Cancer Res. (2009)
- Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study. Razis, E., Briasoulis, E., Vrettou, E., Skarlos, D.V., Papamichael, D., Kostopoulos, I., Samantas, E., Xanthakis, I., Bobos, M., Galanidi, E., Bai, M., Gikonti, I., Koukouma, A., Kafiri, G., Papakostas, P., Kalogeras, K.T., Kosmidis, P., Fountzilas, G. BMC. Cancer (2008)
- Three case reports of hand-foot syndrome with gefitinib. Razis, E., Karina, M., Karanastassi, S., Fountzilas, G. Cancer Invest. (2006)